logo

Quick Facts

Share

Continental AG (CTTAY.PK) reported preliminary consolidated sales of the Group for the third quarter of fiscal 2020 of EUR 10.295 billion, versus EUR 11.103 billion in the prior year quarter. Adjusted EBIT margin for the quarter was 8.1%. Sales in Automotive Technologies declined to EUR 4.101 billion,...

Landstar System, Inc. (LSTR) Wednesday reported third-quarter profit of $61.89 million or $1.61 per share, up from $53.25 million or $1.35 per share last year. Revenues increased to $1.09 billion from $1.01 billion last year. Analysts polled by Thomson Reuters estimated earnings of $1.37 per share...

TRATON GROUP announced that it has experienced a faster market recovery in the third quarter of 2020 than expected, despite ongoing Covid-19 pandemic still having significant impact on the business. Based on preliminary figures, TRATON expects nine-month period Sales revenue of around EUR 15.7 billion,...

Graco Inc. (GGG) Wednesday reported third-quarter net income of $114.1 million or $0.66 per share, up 36% from $84.1 million or $0.49 per share last year. Adjusted earnings improved to $0.59 per share from $0.45 per share last year. Sales for the quarter grew 10% to $439.3 million from $400.6 million...

Pfizer Inc. (PFE) presented the full analysis from one of its phase 3 studies which evaluated the safety and immunogenicity of its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate in adults 18 years of age or older not previously vaccinated against pneumococcal disease. In the study, researchers...

Knight-Swift Transportation Holdings Inc. (KNX) reported third quarter adjusted earnings per share of $0.79 compared to $0.48, a year ago. On average, 17 analysts polled by Thomson Reuters expected the company to report profit per share of $0.63, for the quarter. Analysts' estimates typically exclude...

CRISPR Therapeutics (CRSP) reported positive top-line results from the ongoing phase 1 CARBON trial evaluating the safety and efficacy of CTX110, an allogeneic CAR-T cell therapy targeting CD19+ B-cell malignancies. In the study, 50% complete response rate was achieved at three months in the Dose Level...

Travelzoo (TZOO) reported a third quarter loss per share from continuing operations of $0.10, compared to profit of $0.21 per share, a year ago. On average, four analysts polled by Thomson Reuters expected the company to report a loss per share of $0.19, for the quarter. Analysts' estimates typically...

UniFirst Corp. (UNF) reported that its fourth quarter earnings per share decreased to $1.66 from $2.40, a year ago. On average, four analysts polled by Thomson Reuters expected the company to report profit per share of $1.61, for the quarter. Analysts' estimates typically exclude special items. Fourth...

Moody's Corp. (MCO) said Wednesday it has acquired Acquire Media or AM, an aggregator and distributor of curated real-time news, multimedia, data, and alerts, from Naviga, Inc., a provider of content engagement solutions for the global media industry. The company noted that the acquisition of AM will...

While reporting financial results for the third quarter on Wednesday, Amphenol Corp. (APH) reinstated its earnings, adjusted earnings and sales guidance for the full-year 2020, above analysts' expectations. It also provided outlook for the fourth quarter and raised quarterly dividend 16 percent. The...

While reporting its financial results for the third quarter on Wednesday, NextEra Energy, Inc. (NEE) said that due to the four-for-one stock split approved by its board in mid-September, it has updated its full-year adjusted earnings outlook ranges to reflect the increase in outstanding shares. For...

NextEra Energy Partners LP (NEP) reported third-quarter 2020 net income attributable to the company of $56 million or $0.76 per share, compared to a loss of $72 million or $1.21 per share in the prior year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.44 per share...

Gilead Sciences, Inc. (GILD) announced Wednesday that new 48-week data from the BRAAVE 2020 study shows Biktarvy as an effective treatment regimen in Black Americans with HIV. BRAAVE 2020, a Phase 3 clinical trial, is evaluating the safety and efficacy of switching to Biktarvy (bictegravir 50 mg/emtricitabine...

Nasdaq, inc. (NDAQ) announced Wednesday that Michael Ptasznik has decided to retire from his position as Chief Financial Officer effective February 28, 2021. Ptasznik will be succeeded by Ann Dennison, Nasdaq's Senior Vice President, Controller and Chief Accounting Officer. Dennison will assume the role...

Follow RTT